Skip to content

Drug interactions

Canagliflozin-metformin + Everolimus

Severity: Moderate

Canagliflozin-metformin and Everolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Everolimus commonly causes hyperglycemia and hyperlipidemia, which can undermine glucose control in patients taking antidiabetic drugs. Doses of antidiabetics may need to be increased.

What this interaction means in plain words

Canagliflozin-metformin and Everolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Canagliflozin-metformin belongs to Endocrine; Everolimus belongs to Oncology.

Evidence level: Moderate

Why it happens

mTOR inhibition impairs insulin signaling and beta-cell function, causing insulin resistance.

What to do

Monitor fasting glucose before and during everolimus therapy, and intensify antidiabetic treatment if hyperglycemia develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Canagliflozin-metformin and Everolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Canagliflozin-metformin with Everolimus?

MediHelp rates the interaction as moderate. Canagliflozin-metformin and Everolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Everolimus commonly causes hyperglycemia and hyperlipidemia, which can undermine glucose control in patients taking antidiabetic drugs. Doses of antidiabetics may need to be increased.

How serious is the interaction between Canagliflozin-metformin and Everolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor fasting glucose before and during everolimus therapy, and intensify antidiabetic treatment if hyperglycemia develops.

What other medicines interact with Canagliflozin-metformin?

MediHelp also lists interactions of Canagliflozin-metformin with, for example, Contrast media, Diatrizoate, Diatrizoate meglumine / diatrizoate. The full list is on the Canagliflozin-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in